NEWS - Apr 26, 2016 Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day Read more
NEWS - Apr 20, 2016 Relmada Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day Read more
NEWS - Apr 14, 2016 Relmada Therapeutics, Inc. Provides Update on Nasdaq Up-Listing Process Read more
NEWS - Mar 1, 2016 Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated Read more
NEWS - Feb 2, 2016 Relmada Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference Read more
NEWS - Jan 26, 2016 Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern Read more
NEWS - Jan 11, 2016 Relmada Therapeutics Selected to Present at 2016 Biotech Showcase™ in San Francisco Read more
NEWS - Jan 4, 2016 Relmada Therapeutics Successfully Completes Multiple Ascending Dose Study of d-Methadone for Neuropathic Pain Read more
NEWS - Dec 30, 2015 Relmada Therapeutics Announces Results of Annual Meeting of Stockholders Read more
